Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Poschel

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|August 1, 1981
Pyrazolodiazepines. 3. 4-Aryl-1,6,7,8-tetrahydro-1,3-dialkylpyrazolo[3,4-e][1,4]diazepines as antidepressant agentsH A DeWald, S Lobbestael, B P Poschel
Journal of Medicinal Chemistry|March 1, 1981
Cognition-activating properties of 3-(Aryloxy)pyridinesD E Butler, B P Poschel, J G Marriott
Experientia|November 15, 1985
Arousal deficit shown in aged rat's quantitative EEG and ameliorative action of pramiracetam compared to piracetamB P Poschel, P M Ho, F W Ninteman
Cells|September 9, 2022
IRF8: Mechanism of Action and Health ImplicationsHannah R Moorman, Yazmin Reategui, Dakota B Poschel, et al.
Psychopharmacologia|February 27, 1974
Pyrazapon (CI-683): a new antianxiety agentB P Poschel, D A McCarthy, G Chen, et al.
Life Sciences|October 15, 1974
Intracranial reward after 5,6-dihydroxytryptamine: further evidence for serotonin's inhibitory roleB P Poschel, F W Ninteman, J R McLean, et al.
Experientia|September 15, 1985
Pharmacologic therapeutic window of pramiracetam demonstrated in behavior, EEG, and single neuron firing ratesB P Poschel, P M Ho, F W Ninteman, et al.
Electroencephalography and Clinical Neurophysiology|February 1, 1987
Growing familiarity with the test situation augments the vigilance deficit of aged ratsB P Poschel, P M Ho, M J Callahan, et al.
Blood Immunology & Cellular Therapy|February 12, 2026
Lipid Nanoparticle Fas Gene Therapy Suppresses Autoimmune Lymphoproliferative Syndrome in MiceDakota B Poschel, Zainab Tiamiyu, Priscilla Redd, et al.
Cancers|November 18, 2020
Osteopontin: A Key Regulator of Tumor Progression and ImmunomodulationHannah R Moorman, Dakota Poschel, John D Klement, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|August 1, 1981
Pyrazolodiazepines. 3. 4-Aryl-1,6,7,8-tetrahydro-1,3-dialkylpyrazolo[3,4-e][1,4]diazepines as antidepressant agentsH A DeWald, S Lobbestael, B P Poschel
Journal of Medicinal Chemistry|March 1, 1981
Cognition-activating properties of 3-(Aryloxy)pyridinesD E Butler, B P Poschel, J G Marriott
Experientia|November 15, 1985
Arousal deficit shown in aged rat's quantitative EEG and ameliorative action of pramiracetam compared to piracetamB P Poschel, P M Ho, F W Ninteman
Cells|September 9, 2022
IRF8: Mechanism of Action and Health ImplicationsHannah R Moorman, Yazmin Reategui, Dakota B Poschel, et al.
Psychopharmacologia|February 27, 1974
Pyrazapon (CI-683): a new antianxiety agentB P Poschel, D A McCarthy, G Chen, et al.
Life Sciences|October 15, 1974
Intracranial reward after 5,6-dihydroxytryptamine: further evidence for serotonin's inhibitory roleB P Poschel, F W Ninteman, J R McLean, et al.
Experientia|September 15, 1985
Pharmacologic therapeutic window of pramiracetam demonstrated in behavior, EEG, and single neuron firing ratesB P Poschel, P M Ho, F W Ninteman, et al.
Electroencephalography and Clinical Neurophysiology|February 1, 1987
Growing familiarity with the test situation augments the vigilance deficit of aged ratsB P Poschel, P M Ho, M J Callahan, et al.
Blood Immunology & Cellular Therapy|February 12, 2026
Lipid Nanoparticle Fas Gene Therapy Suppresses Autoimmune Lymphoproliferative Syndrome in MiceDakota B Poschel, Zainab Tiamiyu, Priscilla Redd, et al.
Cancers|November 18, 2020
Osteopontin: A Key Regulator of Tumor Progression and ImmunomodulationHannah R Moorman, Dakota Poschel, John D Klement, et al.
Pageof 4